Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1236
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
-1.26M
-
Total reported value, excl. options
-
$13.6B
-
Value change
-
-$127M
-
Put/Call ratio
-
0.75
-
Number of buys
-
490
-
Number of sells
-
-556
-
Price
-
$96.73
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q1 2024
1,357 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q1 2024.
NOVARTIS AG - Ordinary Shares (NVS) has 1,236 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
of 2.18B outstanding shares and own 6.42% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (12.4M shares), Dodge & Cox (12.4M shares), MORGAN STANLEY (7.26M shares), DIMENSIONAL FUND ADVISORS LP (6.02M shares), LOOMIS SAYLES & CO L P (5.92M shares), FRANKLIN RESOURCES INC (5.7M shares), BANK OF AMERICA CORP /DE/ (4.89M shares), WELLINGTON MANAGEMENT GROUP LLP (4.59M shares), GOLDMAN SACHS GROUP INC (3.06M shares), and RENAISSANCE TECHNOLOGIES LLC (2.94M shares).
This table shows the top 1236 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.